Sep 14 |
Quantum BioPharma Closes Private Placement Offering
|
Sep 9 |
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis
|
Sep 9 |
Quantum Biopharma regains Nasdaq compliance
|
Sep 6 |
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
|
Aug 30 |
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80
|
Aug 30 |
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT"
|
Aug 23 |
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
|
Aug 15 |
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM"
|
Aug 10 |
FSD Pharma Announces Share Consolidation and Name Change
|
Aug 9 |
US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results
|